During the genomic era, a large amount of whole-genome sequences accumulated, which identified many hypothetical proteins of unknown function. Rapidly, functional genomics, which is the research domain that assign a function to a given gene product, has thus been developed. Functional genomics of intracellular pathogenic bacteria exhibit specific peculiarities due to the fastidious growth of most of these intracellular micro-organisms, due to the close interaction with the host cell, due to the risk of contamination of experiments with host cell proteins and, for some strict intracellular bacteria such as Chlamydia, due to the absence of simple genetic system to manipulate the bacterial genome. To identify virulence factors of intracellular pathogenic bacteria, functional genomics often rely on bioinformatic analyses compared with model organisms such as Escherichia coli and Bacillus subtilis. The use of heterologous expression is another common approach. Given the intracellular lifestyle and the many effectors that are used by the intracellular bacteria to corrupt host cell functions, functional genomics is also often targeting the identification of new effectors such as those of the T4SS of Brucella and Legionella.
INTRODUCTION
In the late 1990s, the development of automated-DNA sequencing revolutionized microbiology through the availability of complete genomes of bacteria. The first bacterial genome sequence was reported for the bacterial pathogen Haemophilus influenzae in 1995 [1] . The availability of a complete genome sequence rapidly appeared to be insufficient to understand the complexity of the bacterial world. The genome sequence data are not an end by itself but rather the starting point to raise testable functional hypotheses. Thus, the transition to the 21st century gave rise to a large increase of research in functional genomics, often referred as the postgenomic era ( Figure 1 ). Functional genomics consist to assign a function to a protein encoded by a given gene. A key feature of functional genomics is the 'genome-wide' approach that requires adapting the experimental design to large-scale research. Basically, functional genomics is based onto two main approaches: the sequence-based and the experiment-based function assignment. Sequencebased functional genomics relies mainly on similarity of sequence at nucleotide and/or protein levels as well as, the overall structure and composition of a genome. This approach provides clues but does not establish gene product function and needs experimental verification. On the other hand, experience-based functional genomics relies on experiments performed at different levels such as DNA (transpositional screen and random mutagenesis), RNA (microarrays and RNAseq) and protein (2D gel followed by mass spectrometry, ORFeome, heterologous expression, etc.). Studying the function at the protein level helps characterizing directly the molecular actors in the cell and also includes most functional screens such as protein-protein interactions, subcellular localization as well as, secretion/ translocation screens.
Functional genomics was first applied to model organisms such as Escherichia coli and Bacillus subtilis and then to pathogenic bacteria to gain insight on their virulence factors. Functional genomics of intracellular bacteria cannot be directly extrapoled from functional genomics data of E. coli because gene content and function largely reflects the ecology of a given bacterium and sustained host-pathogen interactions shape the bacterial genomes of intracellular bacteria. This review is devoted to functional genomics of facultative and obligate intracellular pathogenic bacteria. Obligate intracellular pathogenic bacteria only proliferate inside host cells and no defined media are yet available that sustain their bacterial growth, whereas facultative intracellular bacteria may be grown axenically on synthetic media. Functional genomics of intracellular bacteria implies two major challenges: (i) to distinguish the bacterial components of interest from the cellular fraction of the host eukaryotic cell and (ii) the low number of intracellular bacteria at early time point postinfection (p.i.) (before bacterial proliferation) forces the experimenter to deal with low amount of bacterial components. Moreover, the absence of simple genetic system for some strict intracellular bacteria, such as Chlamydia spp., is another challenge that explains the large variety of functional genomics approaches that have been developed by chlamydologists. In addition to Chlamydia, this review will also focus on functional genomics applied to study two facultative intracellular pathogenic bacteria, Brucella spp. and Legionella spp. and will present the different strategies used to identify the effectors translocated into the host cell thanks to their type IV secretion system (T4SS).
FUNCTIONAL GENOMICS OF BRUCELLA Generalities
Brucella spp. are the etiological agent of brucellosis, a widespread worldwide zoonosis affecting a large range of mammals including humans and responsible of dramatic economical losses in endemic countries. Brucella spp. are Gram-negative bacteria belonging to alpha-2 subclass of Proteobacteria [2] . The Brucella genus is divided into 10 species according to their hosts [3, 4] . Brucella spp. are able to infect professional and nonprofessional phagocytes. Once internalized, Brucella resides in a vacuole called 'Brucella-containing vacuole', which successively interacts with endocytic compartments. Then, Brucella reaches the endoplasmic reticulum (ER) at particular sites, the ER exit sites (ERES), where it extensively proliferates [5] [6] [7] .
Brucella genomes
The first complete Brucella genomes were reported in 2002 for B. melitensis strain 16M and B. suis strain 1330 [8, 9] . The complete genome of B. abortus was published in 2005 [10] . Before the availability of complete genome sequence, several groups used transposon mutagenesis and signature-tagged transposon mutagenesis to identify virulence factors [11] [12] [13] [14] [15] . These experiments were essentially performed invitro on eukaryotic cells and led to the identification of genes essential for intracellular survival. These gene products were involved in various pathways such as amino acid and DNA metabolism, lipopolysaccharide (LPS) biosynthesis and the T4SS, which suggested that Brucella genome does not contain toxins and other canonical virulence factors used by other pathogens.
ORFeome of Brucella
In 2004, the first B. melitensis ORFeome was constructed [16] . The B. melitensis ORFeome is a library of all protein-encoding open reading frames (ORF) cloned in an entry vector compatible with the Gateway cloning technology, easily transferable in expression vector by recombination. The ORFeome is a convenient resource for highthroughput functional genomics and can be used for various purposes such as protein overexpression, mutant construction, interaction mapping, etc. Various screens based on the ORFeome availability were performed such as (i) functional screen in yeast for anti-apoptotic effector candidate, (ii) screen for proteins with a polar localization in B. abortus or (iii) yeast two-hybrid between all B. melitensis proteins and human phagosomal protein or ERES-associated proteins [17] [18] [19] [20] .
Thanks to the presence of the same flanking sequences for each coding sequence, the ORFeome is also useful for the construction of a polymerase chain reaction (PCR) product microarrays for the global analysis of gene expression of Brucella in laboratory conditions [21] .
Transcriptional analysis of Brucella
Transcriptional analysis by using microarrays was essentially performed to study the global regulation of a transcriptional regulator. This was the case of BvrR/S, the two component system essential for Brucella virulence [22] . The genes regulated by BvrR/S were determined by parallel wholegenome microarray analyses of the wild type and the bvrR mutant strains grown under the same conditions [23] . A similar approach was used for VjbR and BabR, two transcriptional factors belonging to LuxR family responding to quorum sensing autoinducer, by combining proteomic study to genome microarray analyses [24] [25] [26] [27] . The aim of this work was to identify the quorum-sensing regulon by focusing on the most likely targets. The putative targets included those identified by combining proteomic and microarray analysis and those by the microarray analysis alone confirmed by quantitative reverse transcriptase-PCR (qRT-PCR) or chromatin immunoprecipitation [27] .
Other transcriptomic studies were performed to identify differences in global gene expression level between bacteria subjected to different stimuli or in different stages of axenic growth or intracellular growth. Rossetti et al. [28] performed a microarray analysis between B. melitensis at the late logarithmic phase of growth (the most invasive culture) and stationary phase (the least invasive). The majority of upregulated genes in late-log growth phase were associated with growth, including DNA replication, transcription, translation, intermediate metabolism, energy production and conversion, membrane transport, and biogenesis of the cell envelope and outer membrane. Another study characterized the transcriptional profile at 4 h (nonproliferative phase) and 12 h (proliferative phase) after infection of HeLa cells with B. melitensis. As many as 151 and 115 genes were differentially expressed at 4 and 12 h p.i., compared with the inoculum (a culture at late-log phase of growth). These genes mainly involved in growth and metabolism were downregulated at 4 h p.i. and upregulated at 12 h p.i. [29] . The aim of these two studies was first to identify genes encoding proteins (i) involved in invasion by comparing transcriptional profile between the most and the least invasive growth phases of B. melitensis cultures and (ii) involved in survival and proliferation (by comparing transcriptional profile at 4 and 12 h p.i). The results presented in these studies reflect a global adaptation. It is therefore difficult to identify a single gene or a set of gene involved in the invasion, survival or proliferation.
The recent advance in RNAseq provides a novel approach for transcriptomic studies where host and pathogen can be both analyzed in parallel. This technique also allows the identification of the transcription start site (TSS), alternative TSS and operon organization as well as noncoding RNAs, antisense RNAs, and 5 0 -/3 0 -untranslated regions. Small regulatory RNAs are involved in posttranscriptional regulation and even in modification of protein activity. Hfq protein binds RNA and is usually required for the function and/or stability of this family of sRNAs, in Gram-negative bacteria [30] . The presence of hfq gene in B. abortus genome suggests that such a sRNA regulation exist. Until now, only two sRNAs were identified which are both orthologous to AbcR1 and 2 of A. tumefaciens [31] . Moreover, the small regulatory RNAs of Brucella still remain poorly known and RNAseq approach should help to study this domain.
Proteomics investigations
The first proteomic study of Brucella was performed on bacterial cells grown on blood agar in aerobic condition [32] . A total of 883 proteins spots were detected on 2D gel among which 440 proteins were identified by mass spectrometry. These proteins represent 187 genes that correspond to 6% of the predicted genes present in the genome. Later, various proteomic studies were performed on infected cells or on bacteria grown under micro-aerobic or anaerobic conditions [33] [34] [35] . It was reported that the basal metabolism is reduced under micro-aerobic and anaerobic conditions, which is expected with low or absence of growth. Under these both conditions, glycolysis and denitrification were favored. When oxygen became limiting, basic metabolism processes were maintained and various respiratory pathways were observed. This flexibility confers to Brucella an advantage to survive in low oxygen environments such as damaged host tissues [34] . Lamontagne et al. [35] showed that Brucella prepare for cell division soon after their internalization in mouse macrophages by overproducing several proteins involved in division and DNA metabolism, such as PleC and XseA. In addition to provide such functional information, proteomic studies can also be useful to confirm that proteins were correctly annotated in term of length and that they are produced [36] .
BrucellaVirB T4SS
The T4SS of Brucella was discovered in 1999, by a transposon mutagenesis screen for mutants attenuated during infection of HeLa cells. The involvement of the T4SS VirB in Brucella virulence and its regulation were extensively studied [5, 11, 15, 25, [37] [38] [39] [40] . Briefly, virB expression is regulated by BvrR/S and VjbR regulators [25, 39] . It was also reported that VirB T4SS is required to sustain interaction with the ER and generate a proliferative organelle, probably through the action of translocated effectors into the host cell or the vacuolar membrane [5] . A common strategy to identify effectors relies on bioinformatic approaches. One study hypothesized that proteins translocated by VirB must be co-regulated with the virB operon by the VjbR regulator [41] . A conserved motif, in the virB promoter, required for VjbR activation was determined and then 144 promoters containing this motif were identified. For interesting candidates, translocation into macrophages using TEM-b-lactamase reporter were tested. Thus, two proteins, VceA and VceC, were reported as the first T4SS substrates. A second genome-wide bioinformatics screen was initiated to identify additional effectors. This screen was based on different criteria such as the homology to known effectors and the occurrence of eukaryoticlike domain or motif. Using this bioinformatic approach, 84 B. abortus putative effectors were identified [42] . Translocation of these putative effectors was tested using adenylate cyclase reporter and six were translocated into the eukaryotic cytoplasm.
Another strategy to identify effectors, consist to focus on a particular feature of these effectors such as their interactions with host proteins, as well as their translocation into host cell cytoplasm. In this prospect, a genome-wide yeast two-hybrid between all B. melitensis and human phagosomal protein was performed [18] . This approach was possible thanks to the availability of both human and B. melitensis ORFeome. A specific interaction was identified between the human Rab GTPase Rab2 and a Brucella protein called RicA. This interaction was confirmed by GST pull down and RicA was shown to be translocated into host cell cytoplasm of macrophages using the TEM-b-lactamase reporter. Functional screen in yeast to identify anti-apoptotic effector candidates and translocation screen using the Yersinia YopP as a reporter system [17, 43] are alternative strategies used to identify T4SS effectors.
Despite using many different approaches, Brucella effectors still remain poorly characterized possibly due to the difficulties to adapt tools and experiments to this biosafety level 3 bacterial pathogen.
FUNCTIONAL GENOMICS OF LEGIONELLA Generalities
Legionella pneumophila is a Gram-negative bacterium commonly found in aquatic environment where it replicates inside protozoan hosts [44, 45] . L. pneumophila is the causing agent of a severe pneumonia, called Legionnaires' disease [46] [47] [48] . The alveolar macrophages are the primary sites of bacterial proliferation. The L. pneumophila virulence seems to rely on its ability to avoid phagosome-lysosome fusion, because mutants defective for this particular phenotype are unable to proliferate inside the host cell and thus to cause the disease [49, 50] . Once inside the cell, L. pneumophila reside in a vacuole called Legionella containing vacuoles (LCV). The LCV rapidly acquire the characteristics of an ER-like compartment by recruiting vesicles from the early secretory pathway [51] . This is essential for bacterial proliferation and require a functional Dot/Icm type IV secretion system (Dot/Icm T4SS) that translocates effector proteins and represents a major virulence factor (discussed later) [52] .
Legionella genomes
The three first complete genomes of L. pneumophila were published in 2004 and a fourth sequence from the same species was reported in 2007 [53] [54] [55] . Many important factors involved in internalization and intracellular proliferation have been identified during the pregenomic era such as Dot/Icm type IV secretion system, the type II secretion system Lsp and the Mip (macrophage infectivity potentiator) [56, 57] .
The availability of complete L. pneumophila genomes is an open window to better understand the L. pneumophila biology. For example, sequence analysis allowed the identification of a putative type I secretion system (Lss) encoded by the lssXYZABD locus [58] . Legionella pneumophila genome was also screened to identify patatin-like proteins (PLPs) and 11 PLPs were identified designated PatA to PatK. These PLPs form a new family of phospholipases. Four of these PLPs (PatA/VipD, PatC/VpdA, PatG/VpdB and PatF/VpdC) have been identified and characterized previously [59, 60] .
Transcriptional analyses of Legionella
The first transcriptional study of L. pneumophila using microarrays was performed during infection of its natural host, i.e. Acanthamoeba castellanii [61] . Virulence traits such as Dot/Icm substrates, factors associated to invasion, virulence and motility as well as more than 90 proteins without characterized function, were overexpressed during the transmissive phase (>10 h p.i.) compared with the proliferative phase (<10 h p.i.). Another transcriptional analysis was performed on L. pneumophila biofilm cells by comparing transcriptional profile of sessile cells with two distinct populations of planktonic cells [62] . The results showed that sessile cells have a similar gene expression profile to proliferative phase L. pneumophila. Recently, to detect putative virulence factors involved in resistance to macrophages, the transcriptional response of L. pneumophila once internalized by human macrophages, was analysed at 0, 6 and 18 h p.i. and was compared with exponential and postexponential axenic growth. Interestingly, 8 of the 10 most highly induced genes were of unknown function. These genes could represent virulence traits. Three new translocated effectors were identified by scanning the genome to detect regions enriched in genes without assigned function and showing a similar expression patterns to their neighboring effector genes [63] .
In addition, many putative sRNA molecules were identified by both bioinformatic analyses and deep RNA-sequencing on L. pneumophila grown in broth and inside A. castellanii [64] [65] [66] [67] . Thus, deep RNA-sequencing gave new insights on the global transcriptional regulation and response to particular conditions and also helped identifying small noncoding RNA involved in the posttranscriptional regulation.
Proteomics investigations
The first proteomic study performed on L. pneumophila was reported in 2005. This work on total cell extracts provided a reference map for further investigations [68] . A proteomic approach was also used to identify the T2SS secretome [69, 70] , as well as the whole secretome [71] and the membranome and surfaceome [72] . Proteomic analysis was also performed at both exponential phase and postexponential phase (virulent) of L. pneumophila, to confirm differences observed at the transcription level and to identify proteins possibly associated to virulence [73] . This led to the identification of 68 proteins among which 64 were overproduced at the postexponential phase. Of these, nine proteins of unknown function were found, among which six were demonstrated specific for L. pneumophila by southern blot analysis. Two of them were associated to hemolysis by conducting contact dependent hemolysis assay using sheep red blood cells (SRBC) and two were translocated into macrophages by the Dot/ Icm T4SS, demonstrating the usefulness of proteomics to decipher protein functions.
Legionella Dot/Icm T4SS
The T4SS Dot/Icm was identified by various selections and screens for L. pneumophila mutants defective for intracellular growth and/or defective for macrophage killing. These mutants were called dot for defect in organelle trafficking, in Isberg lab, and icm for deficient in intracellular multiplication in Shuman lab [74] [75] [76] [77] [78] [79] . Up to now, 26 dot/icm genes have been identified and are essential for intracellular growth, in particular to prevent phagosome-lysosome fusion.
More than 300 L. pneumophila effectors have been identified using an arsenal of methods such as bioinformatic screens for genes encoding eukaryotic-like domain, genetic screens for particular phenotypes, yeast screens and translocation screens. Sequencing and analysis of the Legionella genome identified a wide variety of proteins exhibiting eukaryotic-like domains such as ankyrin repeat, Sel-1, SET, Sec7 motifs, U-box and F-box domains. Using these bioinformatic approaches, a L. pneumophila protein, called RalF, containing a Sec7 homology domain was identified [80] . Sec7 homology domains are found in a family of eukaryotic ARF-GEF, which stimulates exchange of GDP for GTP. Arf1 is a small GTPase involved in the regulation of the vesicle traffic between the ER and the Golgi. It was reported that RalF is required for the localization of Arf1 on phagosomes containing L. pneumophila. Moreover RalF is translocated through the phagosomal membrane by the T4SS Dot/Icm. RalF was the first translocated substrate of the T4SS with an identified function.
One interesting genetic screen relied on the identification of mutant strains, obtained by transposon mutagenesis, exhibiting a similar phenotype than that of the dotL mutant, i.e. lethality [81] . This lethality is likely due to the assembly of a poison Dot/Icm complex, caused by the dysregulation of the molecular flow through the translocator. This study allowed the identification of LidA (lowered viability in the presence of dot). LidA function was then extensively studied [82] [83] [84] [85] [86] .
The yeast was also exploited to identify and characterized L. pneumophila effectors. A yeast lethality screen was performed to identify L. pneumophila proteins, which interfere with yeast growth. This screen led to the identification of YlfA for yeast lethal factor. YlfA was also shown to be translocated by the Dot/Icm apparatus and is associated with vesicles of the early secretory pathway including ER [87] . The yeast can be also used to identify proteins which cause a membrane trafficking (vacuole protein sorting [VPS]) defect in yeast. Using this screen, three proteins which inhibit vacuolar traffic were identified called VipA (VPS inhibitory protein), VipD and VipF [59] . These three proteins are also translocated into host macrophages through the Dot/ Icm T4SS. VipD possesses a patatin domain and is thus also called PatA.
All these methods considerably improved our knowledge on L. pneumophila intracellular life cycle and subversion of host cell processes to its own advantage. Moreover, yeasts represent a useful tool to define the function of putative effectors.
FUNCTIONAL GENOMICS OF CHLAMYDIA Generalities
Chlamydia trachomatis and C. pneumoniae are important human pathogens causing ocular infection and respiratory diseases such as pneumonia, respectively.
Until now, we are still unable to genetically manipulate these organisms by targeted mutagenesis or transposon mutagenesis, prompting the development of other approaches. One major reason for the absence of genetic system to manipulate the genome of Chlamydia, resides in the obligate intracellular life cycle of these bacteria. The chlamydial development cycle is indeed characterized by two distinct developmental stages, which are morphologically and functionally different. Elementary bodies (EBs) are the infectious form that may survive extracellularly whereas reticulate bodies (RBs) are noninfectious and proliferate inside the host cell. Basically, EBs are internalized and differentiate into RBs, which replicate by binary fission. RBs then redifferentiate into EBs, which are released after cell lysis. Finally, EBs initiate a new infection cycle.
Chlamydia genomes and genetic approaches
The complete genome sequence of C. trachomatis and C. pneumoniae were published in 1998 and 1999, respectively [88, 89] .
One interesting approach to tackle the intractability of Chlamydia is the use of a combinatorial approach coupling a chemical mutagenesis with wholegenome sequencing and a system of DNA exchange within infected cells [90] . Practically, Chlamydia infected Vero cells were treated with the alkylating agent ethylmethylsulfonate. Mutated Chlamydia were then used to reinfect a monolayer of Vero cells, overlaid with agar to observe plaque formation. Mutants were classified according to their plaque morphotypes and the whole genome of mutants sequenced to identify mutated genes sharing the same phenotype. Finally, co-infection between the wild type and mutant strains were performed to obtain recombinants where particular mutated genes could be linked to a phenotype. This method led to the identification of four mutants which form large granular plaques (Gnr). Three were mutated in the glgB gene encoding a glycogen-branching enzyme. Microscopic analysis of HeLa cells infected with Gnr mutants showed an accumulation of large precipitates in the lumen of inclusions, likely glycogen. Recombinant strains were obtained to address the link between genotype and phenotype and showed that all strains with a mutated glgB (even single mutation) were accumulating glycogen inside inclusion. Altogether, a loss-of-function of glgB is leading to the accumulation of glycogen. Similarly, in the Gnr4 mutant, a mutation was identified in the gspE gene which is homologous to ATPases of the type II secretion system. One hypothesis is that gspE mutant accumulates glycogen because a key glycogen hydrolase is not secreted. Interestingly, gspE mutant is attenuated during HeLa cells infection compared with wild type and glgB mutant strains. This suggests that the T2SS is involved in the secretion of other factors essential for bacterial survival. This combinatorial approach should be applicable to other genetically intractable pathogenic bacteria.
Transcriptional analyses of Chlamydia
Transcriptomic and proteomic analyses are important to study the global adaptation of Chlamydia to their host. Microarray analyses of the temporal gene expression during the developmental cycle have been performed, respectively on C. trachomatis serovar L2 and D [91, 92] and on C. pneumoniae [93] . Belland et al. [91] identified 29 early genes expressed as early as 1 h p.i.. Analysis of these genes suggests that Chlamydia established systems for nutrient acquisition and modify its inclusion by expressing particular genes during the early stage of infection. Transcriptomic studies allowed the definition of a new class of genes called the 'very late' (or 'tardy' genes), in addition to the 'late' genes. Basically, 'late' genes encode early proteins required for EBs infection and 'tardy' correspond to genes which mRNA transcripts are present in EBs. A total of 26 and 70 'late' genes were, respectively, identified by Belland et al. [91] and Nicholson et al. [92] . Among these genes, omcAB and hctAB were previously characterized as 'late' genes. HctAB encodes HctA and HctB, two chlamydial histone-like proteins, which mediate chromosomal condensation during the differentiation of RBs to EBs. OmcAB encodes for OmcA and OmcB are two cysteine-rich outer membrane proteins interacting with OmpA, the major outer membrane protein, to form a highly disulfide crosslinked complex. This complex is considered essential for the resistance of EBs to osmotic stress when outside host cells, because Chlamydia do not have a classical peptidoglycan layer.
Recently, RNAseq was performed on the C. trachomatis L2b and C. pneumoniae CWL-029 on purified EBs and RBs [94, 95] . For C. trachomatis, 363 TSSs have been mapped and 43 noncoding RNA identified. As many as 83 genes showed differential expression level between RBs and EBs [95] . For C. pneumoniae, 565 transcriptional start sites of annotated genes and novel transcripts were mapped.
Semi-quantitative analysis showed significant differences in genes expression between EBs and RBs for 288 genes. Moreover, 75 noncoding RNAs were identified [94] . By intergenic tiling microarray on RNA of C. trachomatis D at 40 h p.i., 34 noncoding RNAs were identified, 16 being confirmed by northern blot [96] . One of the noncoding RNA regulated ftsI expression by inducing degradation of ftsI mRNA. This is especially interesting in other bacterial lineages because FtsI is involved in peptidoglycan synthesis. The true role of FtsI in Chlamydia remains to be determined [97] . Given the susceptibility of Chlamydia to penicillin derivatives, the FtsI and others genes of the fts operon are likely important in chlamydial multiplication and/or in the biosynthesis of the chlamydial peptidoglycan-like layer.
Proteomics investigations
Different proteomic studies using 2D gel and mass spectrometry were performed during the past 10 years to better understand events such as differentiation of EBs to RBs. Several studies were performed on purified EBs or on both purified EBs and RBs, to determine the proteome and study its temporal variation [98] [99] [100] . These studies confirmed that ORFing of C. trachomatis and C. pneumoniae genomes was correct for these hypothetical proteins. It was also showed that the entire set of glycolytic enzymes were present in the so-called ''metabolically inert'' form (EBs), suggesting that there are metabolic flux also in EBs. These results were recently confirmed by a quantitative study showing that proteins of the central metabolism and glucose catabolism were more abundant in EBs, whereas in RBs, proteins involved in ATP generation, proteins synthesis and nutrient transport were predominant [101] .
Proteomic approaches were also used to identify translocated chlamydial proteins into host cell cytoplasm [102, 103] . The first study allowed the identification of CPAF (chlamydial protease or proteasome-like activity factor), a factor previously characterized by Zhong et al. [104] . A second study allowed the identification of CT621, which localized to the host cell cytoplasm and nucleus and whose translocation is dependent of the T3SS [103] .
An ORFeome was recently constructed for C. pneumoniae [105] . The ORFeome is an essential tool for functional genomics of such intractable bacteria allowing functional screens in yeast such as two-hybrid, lethality screen, membrane traffic defect, adhesion assays, as well as screen to identify T3SS translocated proteins, for instance by heterologous expression in Shigella using reporter gene fusions.
Advances in Chlamydia transformation
In one of the pioneering works in this field, Binet and Maurelli [106] constructed pUC plasmid derivatives carrying different lengths of rRNA regions containing four nucleotide substitutions. Three substitutions located in the 16Sr RNA gene conferred resistance to kasugamycin and spectinomycin, and caused a loss of one HpaI restriction site. C. psittaci 6BC was then electroporated with various concentrations of circular or linearized plasmids. Allelic replacements of the endogenous rRNA operon were selected by incubation of the infected cells with the two antibiotics. Allelic replacements were observed at frequencies greater than 10 -6 . This showed that genetic manipulations are feasible in Chlamydia. Recently, C. trachomatis transformation was reported using penicillin selection and calcium chloride treatment of EBs to render them competent [107] . A GFP plasmid was constructed based on the plasmid of the Swedish new variant strain (a strain with a deletion of a 400 bp region in the canonical 7500 kb plasmid of C. trachomatis). This plasmid was used to obtain penicillin resistant C. trachomatis strains expressing gfp. These recent advances in C. trachomatis transformation and mutagenesis by allelic recombination in C. psittaci open the window to future development of genetic tools to perform targeted and random mutagenesis, which could considerably improve our knowledge on the biology of these bacteria [106, 107] .
DISCUSSION
During the last two decades, complete genomes were obtained for many bacteria. All these data are however not sufficient to understand the bacterial biology. This led to the development of functional genomics whose main feature is its genome-wide approach ( Figure 2 ). One challenge of the functional genomics on intracellular pathogen is to discriminate bacterial material from host cell material. The early times postinfection are also critical since there is not yet bacterial proliferation and we have to deal with very small amount of bacteria. Functional genomics approaches are useful to better understand host-pathogen interaction which is tightly regulated by the two interacting partners and leads to accumulating data at the DNA, RNA and protein level. These data are quite difficult to interpret and need to conciliate all three levels. Each approach presents advantages and limitations which are summarized in the Table 1 . One major disadvantage of microarray analysis is that results may be different than results obtained at proteomic level due to posttranscriptional modifications. It is therefore interesting to perform both analyses in parallel on a same sample. The main disadvantage of proteomic studies, using 2D gel and mass spectrometry, is that they require supplementary steps to separate/distinguish host cell proteins from bacterial proteins. RNAseq compared with microarrays, has several advantages, and especially in term of cost and quality of data, but this new technology has not yet been much applied to intracellular pathogenic bacteria. RNAseq also require differentiating bacterial RNA and host cell RNA. This is possible by mapping reads to reference bacterial genome sequence or, before the RNAseq, by a physical separation of bacteria from host cells or by sequential purification steps to isolate bacterial RNA. Genome-wide studies give a global view of the bacterial response to a particular environment. They may be combined with specific functional screens to determine the role of a particular protein.
Extracellular pathogenic bacteria secrete toxins/ enzymes which are considered as virulence factors. For intracellular bacteria, toxins/enzymes counterparts are effector proteins. These proteins are translocated by a secretion system and are involved in the host cell hijacking. Intracellular pathogenic bacteria possess a battery of noncanonical effectors with redundant functions, rendering their identification extremely difficult. In this context, functional genomics approaches are very useful tools.
In the future, functional genomics will increasingly use RNAseq and will likely also investigate bacterial metabolism using metabolomics. The major interest of RNAseq is the identification of noncoding RNAs which are new actors in genes regulation. Noncoding RNA role is still likely underestimated. By giving a snapshot of the metabolites present at a define time, metabolomics will provide important insights into bacterial physiology. The next challenge in the functional genomics field is to integrate data from transcriptomic, proteomic and metabolomic studies to obtain a global picture of the bacterial state in a defined condition and to better characterize host-pathogen interaction.
Key points
Increasing amount of bacterial genome give rise to functional genomics also known as the postgenomic era. Functional genomics consists to give a function to a protein encoded by a gene and relies on 'genome wide' approaches based on in silico analysis or on experiments at the DNA, RNA and protein level. Functional genomics of intracellular pathogen is challenging given their close interaction with the host cell and due to specific constraints such as the risk of contamination with host cell material, and the absence of genetic tool for some bacterial clade such as Chlamydiales. Functional genomics approaches are essential to better understand how intracellular bacteria may corrupt the cell, for example by using specific bacterial effectors. 
